These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 8726959

  • 21. The peripheral-type benzodiazepine receptor ligands [3H]Ro 5-4864 and [3H]PK 11195 bind to the retina of rabbit, but not of turtle.
    Giannaccini G, Martini C, Lucacchini A, Strettoi E, Piccolino M.
    J Neurochem; 1993 Oct; 61(4):1263-9. PubMed ID: 8397291
    [Abstract] [Full Text] [Related]

  • 22. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
    Janis RA, Sarmiento JG, Maurer SC, Bolger GT, Triggle DJ.
    J Pharmacol Exp Ther; 1984 Oct; 231(1):8-15. PubMed ID: 6208356
    [Abstract] [Full Text] [Related]

  • 23. Autoradiographic localization of a calcium channel antagonist, [3H]nitrendipine, binding site in rat brain.
    Quirion R.
    Neurosci Lett; 1983 Apr 29; 36(3):267-71. PubMed ID: 6866333
    [Abstract] [Full Text] [Related]

  • 24. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
    Ferry DR, Goll A, Glossmann H.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul 29; 323(3):276-7. PubMed ID: 6312337
    [Abstract] [Full Text] [Related]

  • 25. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
    Schoemaker H, Langer SZ.
    J Pharmacol Exp Ther; 1989 Feb 29; 248(2):710-5. PubMed ID: 2537412
    [Abstract] [Full Text] [Related]

  • 26. A unitary mechanism of calcium antagonist drug action.
    Murphy KM, Gould RJ, Largent BL, Snyder SH.
    Proc Natl Acad Sci U S A; 1983 Feb 29; 80(3):860-4. PubMed ID: 6572372
    [Abstract] [Full Text] [Related]

  • 27. [3H]nitrendipine receptors in skeletal muscle.
    Fosset M, Jaimovich E, Delpont E, Lazdunski M.
    J Biol Chem; 1983 May 25; 258(10):6086-92. PubMed ID: 6304026
    [Abstract] [Full Text] [Related]

  • 28. Specific high affinity binding of the calcium channel antagonist, [3H]nitrendipine, to rat liver microsomes.
    Gopalakrishnan V, Triggle CR.
    Can J Physiol Pharmacol; 1984 Sep 25; 62(9):1249-52. PubMed ID: 6498637
    [Abstract] [Full Text] [Related]

  • 29. 2,3-Butanedione inactivates the [3H]nitrendipine binding sites, whereas diethylpyrocarbonate does not.
    Costa B, Giusti L, Martini C, Lucacchini A.
    Neurochem Int; 1996 Dec 25; 29(6):623-7. PubMed ID: 9113129
    [Abstract] [Full Text] [Related]

  • 30. Characterization of calcium antagonist receptors in highly purified porcine cardiac sarcolemma.
    Haase H, Wallukat G, Vetter R, Will H.
    Biomed Biochim Acta; 1987 Dec 25; 46(8-9):S363-9. PubMed ID: 2829862
    [Abstract] [Full Text] [Related]

  • 31. [3H]Nitrendipine binding to calcium channels in bovine and rat pituitary.
    Titeler M, De Souza EB, Kuhar MJ.
    J Neurochem; 1985 Jun 25; 44(6):1955-8. PubMed ID: 2580956
    [Abstract] [Full Text] [Related]

  • 32. NZ-105, a new 1,4-dihydropyridine derivative: correlation between dihydropyridine receptor binding and inhibition of calcium uptake in rabbit aorta.
    Yamashita T, Masuda Y, Sakai T, Tanaka S, Kasuya Y.
    Jpn J Pharmacol; 1991 Nov 25; 57(3):337-48. PubMed ID: 1667534
    [Abstract] [Full Text] [Related]

  • 33. Slow dissociation of the new slow-onset and long-acting calcium antagonist benidipine hydrochloride from 3H-nitrendipine binding sites.
    Ishii A, Nishida K, Oka T, Nakamizo N.
    Arzneimittelforschung; 1988 Nov 25; 38(11A):1681-3. PubMed ID: 3219140
    [Abstract] [Full Text] [Related]

  • 34. Characterization of membrane calcium channels in nonpregnant and pregnant human uterus.
    Batra SC, Popper LD.
    Gynecol Obstet Invest; 1989 Nov 25; 27(2):57-61. PubMed ID: 2543611
    [Abstract] [Full Text] [Related]

  • 35. [3H]nitrendipine binding to adrenal capsular membranes.
    Finkel MS, Aguilera G, Catt KJ, Keiser HR.
    Life Sci; 1984 Aug 20; 35(8):905-10. PubMed ID: 6482681
    [Abstract] [Full Text] [Related]

  • 36. High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers.
    Campbell KP, Sharp A, Strom M, Kahl SD.
    Proc Natl Acad Sci U S A; 1986 May 20; 83(9):2792-6. PubMed ID: 3010317
    [Abstract] [Full Text] [Related]

  • 37. Comparison of binding affinities and negative inotropic potencies of the 1,4-dihydropyridine calcium channel blockers in rabbit myocardium.
    Boyd RA, Giacomini JC, Wong FM, Nelson WL, Giacomini KM.
    J Pharmacol Exp Ther; 1987 Oct 20; 243(1):118-25. PubMed ID: 2822893
    [Abstract] [Full Text] [Related]

  • 38. Melatonin reduces 3H-nitrendipine binding in the heart.
    Chen LD, Kumar P, Reiter RJ, Tan DX, Chamber JP, Manchester LC, Poeggeler B.
    Proc Soc Exp Biol Med; 1994 Oct 20; 207(1):34-7. PubMed ID: 7938033
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Solubilization and affinity labeling of a dihydropyridine binding site from skeletal muscle: effects of temperature and diltiazem on [3H]dihydropyridine binding to transverse tubules.
    Kirley TL, Schwartz A.
    Biochem Biophys Res Commun; 1984 Aug 30; 123(1):41-9. PubMed ID: 6089800
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.